Microbot Medical Inc. SEC filings MBOT

Microbot Medical Inc. has 1,004 filings in SEC EDGAR's recent list, going back to May 17, 2011. Its latest annual report, Form ARS, was filed on Nov 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Microbot Medical Inc. SEC filings
Form Description Filed Period
ARS Annual report to shareholders Nov 3, 2026 Dec 31, 2025
DEFA14A Additional proxy material Nov 3, 2026 —
DEF 14A Proxy statement Nov 3, 2026 Nov 3, 2026
8-K Current report
Regulation FD disclosure
Oct 27, 2026 Oct 27, 2026
8-K Current report
Regulation FD disclosure
Oct 23, 2026 Oct 23, 2026
8-K Current report
Regulation FD disclosure
Oct 20, 2026 Oct 14, 2026
8-K Current report
Regulation FD disclosure
Oct 6, 2026 Oct 6, 2026
8-K Current report
Regulation FD disclosure
Sep 28, 2026 Sep 25, 2026
8-K Current report
Regulation FD disclosure
Aug 11, 2026 Aug 11, 2026
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Material agreement, Officer or director change
Aug 7, 2026 Aug 6, 2026
8-K Current report
Regulation FD disclosure
Jul 21, 2026 Jul 21, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 7, 2026 Jul 7, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 30, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Jun 25, 2026 Jun 25, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 23, 2026 Jun 23, 2026
8-K Current report
Regulation FD disclosure
Jun 16, 2026 Jun 16, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 9, 2026 Jun 9, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 2, 2026 Jun 2, 2026
8-K Current report
Regulation FD disclosure, Other events
May 26, 2026 May 26, 2026
8-K Current report
Regulation FD disclosure
May 15, 2026 May 15, 2026
8-K Current report
Regulation FD disclosure, Other events
May 14, 2026 May 14, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Regulation FD disclosure
May 5, 2026 May 5, 2026
8-K Current report
Regulation FD disclosure
Apr 30, 2026 Apr 30, 2026
8-K Current report
Regulation FD disclosure
Apr 22, 2026 Apr 22, 2026
8-K Current report
Regulation FD disclosure
Apr 14, 2026 Apr 14, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 13, 2026 Apr 13, 2026
424B5 Prospectus supplement Apr 10, 2026 —
8-K Current report
Other events
Apr 10, 2026 Apr 10, 2026
10-K Annual report Mar 26, 2026 Dec 31, 2025
8-K Current report
Regulation FD disclosure
Mar 26, 2026 Mar 26, 2026
8-K Current report
Regulation FD disclosure
Mar 24, 2026 Mar 24, 2026
8-K Current report
Regulation FD disclosure
Mar 17, 2026 Mar 17, 2026
8-K Current report
Regulation FD disclosure
Mar 10, 2026 Mar 10, 2026
8-K Current report
Regulation FD disclosure
Mar 4, 2026 Mar 4, 2026
8-K Current report
Regulation FD disclosure
Mar 3, 2026 Mar 3, 2026
8-K Current report
Material agreement, Officer or director change
Feb 24, 2026 Feb 18, 2026
8-K Current report
Regulation FD disclosure
Feb 24, 2026 Feb 24, 2026
8-K Current report
Regulation FD disclosure
Feb 19, 2026 Feb 19, 2026
8-K Current report
Regulation FD disclosure
Feb 12, 2026 Feb 12, 2026
8-K Current report
Regulation FD disclosure
Feb 5, 2026 Feb 5, 2026
8-K Current report
Other events
Jan 12, 2026 Jan 12, 2026
8-K Current report
Regulation FD disclosure, Other events
Nov 26, 2025 Nov 26, 2025
424B3 Prospectus Nov 19, 2025 —
424B3 Prospectus Nov 19, 2025 —
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 5, 2025 Nov 5, 2025
S-3/A Filing Oct 28, 2025 —
S-3/A Filing Oct 28, 2025 —
8-K Current report
Regulation FD disclosure
Oct 16, 2025 Oct 16, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 14, 2025 Oct 14, 2025
S-3 Shelf registration Oct 14, 2025 —
S-3 Shelf registration Oct 14, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 7, 2025 Oct 6, 2025
8-K Current report
Material agreement, Unregistered share sale
Oct 3, 2025 Sep 29, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 1, 2025 Oct 1, 2025
D Filing Sep 30, 2025 —
8-K Current report
Regulation FD disclosure
Sep 23, 2025 Sep 23, 2025
8-K Current report
Officer or director change
Sep 19, 2025 Sep 17, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 16, 2025 Sep 14, 2025
8-K Current report
Regulation FD disclosure
Sep 9, 2025 Sep 9, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 8, 2025 Sep 8, 2025
8-K Current report
Unregistered share sale
Aug 27, 2025 Aug 27, 2025
8-K Current report
Unregistered share sale
Aug 25, 2025 Aug 22, 2025
8-K Current report
Regulation FD disclosure, Other events
Aug 20, 2025 Aug 20, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Unregistered share sale, Regulation FD disclosure, Other events
Aug 5, 2025 Jul 31, 2025
8-K Current report
Unregistered share sale
Jul 30, 2025 Jul 28, 2025
8-K Current report
Regulation FD disclosure
Jul 22, 2025 Jul 22, 2025
S-8 Employee stock plan registration Jul 21, 2025 —
8-K Current report
Unregistered share sale
Jul 17, 2025 Jul 14, 2025
8-K Current report
Regulation FD disclosure
Jul 8, 2025 Jul 8, 2025
8-K Current report
Regulation FD disclosure
Jun 30, 2025 Jun 30, 2025
8-K Current report
Unregistered share sale, Regulation FD disclosure, Other events
Jun 17, 2025 Jun 17, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
Jun 11, 2025 Jun 10, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 9, 2025 Jun 9, 2025
8-K Current report
Regulation FD disclosure
Jun 5, 2025 Jun 5, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Regulation FD disclosure
Apr 30, 2025 Apr 30, 2025
DEF 14A Proxy statement Apr 29, 2025 Apr 29, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
8-K Current report
Unregistered share sale, Regulation FD disclosure
Apr 23, 2025 Apr 21, 2025
PRE 14A Preliminary proxy statement Apr 17, 2025 Apr 17, 2025
8-K Current report
Other events
Apr 17, 2025 Apr 17, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Apr 15, 2025 Apr 14, 2025
8-K Current report
Regulation FD disclosure, Other events
Apr 9, 2025 Apr 9, 2025
424B3 Prospectus Apr 8, 2025 —
424B3 Prospectus Apr 8, 2025 —
424B3 Prospectus Apr 8, 2025 —
424B3 Prospectus Apr 8, 2025 —
424B3 Prospectus Apr 3, 2025 —
EFFECT Filing Apr 2, 2025 —
EFFECT Filing Apr 2, 2025 —
EFFECT Filing Apr 2, 2025 —
EFFECT Filing Apr 2, 2025 —
EFFECT Filing Apr 1, 2025 —
8-K Current report
Regulation FD disclosure
Apr 1, 2025 Apr 1, 2025
POS AM Filing Mar 31, 2025 —
POS AM Filing Mar 31, 2025 —
CORRESP Letter to the SEC Mar 28, 2025 —
POS AM Filing Mar 28, 2025 —
POS AM Filing Mar 27, 2025 —
POS AM Filing Mar 27, 2025 —
S-3/A Filing Mar 27, 2025 —
10-K Annual report Mar 25, 2025 Dec 31, 2024
UPLOAD Letter from the SEC Mar 17, 2025 —
S-3 Shelf registration Mar 10, 2025 —
8-K Current report
Regulation FD disclosure
Mar 4, 2025 Mar 4, 2025
DEFA14A Additional proxy material Feb 28, 2025 —
DEF 14A Proxy statement Feb 28, 2025 Feb 28, 2025
8-K Current report
Regulation FD disclosure, Other events
Feb 25, 2025 Feb 25, 2025
424B3 Prospectus Feb 21, 2025 —
PRE 14A Preliminary proxy statement Feb 18, 2025 Feb 18, 2025
D Filing Feb 18, 2025 —
EFFECT Filing Feb 13, 2025 —
424B3 Prospectus Feb 12, 2025 —
424B3 Prospectus Feb 12, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Feb 12, 2025 Feb 11, 2025
CORRESP Letter to the SEC Feb 11, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Feb 11, 2025 Feb 9, 2025
424B5 Prospectus supplement Feb 11, 2025 —
S-1/A Amended registration statement Feb 10, 2025 —
424B3 Prospectus Feb 10, 2025 —
424B3 Prospectus Feb 10, 2025 —
424B3 Prospectus Feb 10, 2025 —
424B3 Prospectus Feb 10, 2025 —
8-K Current report
Other events
Feb 10, 2025 Feb 10, 2025
UPLOAD Letter from the SEC Feb 7, 2025 —
8-K Current report
Material agreement, Officer or director change
Feb 7, 2025 Feb 5, 2025
S-1 Registration statement Feb 4, 2025 —
8-K Current report
Regulation FD disclosure
Feb 4, 2025 Feb 4, 2025
424B3 Prospectus Feb 3, 2025 —
424B3 Prospectus Feb 3, 2025 —
8-K Current report
Other events
Jan 27, 2025 Jan 27, 2025
8-K Current report
Officer or director change
Jan 24, 2025 Jan 17, 2025
D Filing Jan 22, 2025 —
D Filing Jan 22, 2025 —
8-K Current report
Regulation FD disclosure
Jan 21, 2025 Jan 21, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Jan 10, 2025 Jan 7, 2025
424B5 Prospectus supplement Jan 10, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jan 7, 2025 Jan 6, 2025
424B5 Prospectus supplement Jan 7, 2025 —
424B3 Prospectus Jan 6, 2025 —
424B3 Prospectus Jan 6, 2025 —
8-K Current report
Other events
Jan 6, 2025 Jan 6, 2025
8-K Current report
Regulation FD disclosure
Dec 30, 2024 Dec 30, 2024
8-K Current report
Officer or director change, Shareholder vote results
Dec 19, 2024 Dec 17, 2024
424B3 Prospectus Dec 10, 2024 —
424B3 Prospectus Dec 10, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Dec 10, 2024 Dec 10, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
DEFA14A Additional proxy material Nov 6, 2024 —
ARS Annual report to shareholders Nov 6, 2024 Dec 31, 2023
DEF 14A Proxy statement Nov 6, 2024 Nov 6, 2024
8-K Current report
Regulation FD disclosure
Oct 31, 2024 Oct 31, 2024
424B3 Prospectus Oct 15, 2024 —
424B3 Prospectus Oct 15, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Oct 15, 2024 Oct 15, 2024
8-K Current report
Listing notice
Oct 11, 2024 Oct 9, 2024
424B3 Prospectus Oct 1, 2024 —
424B3 Prospectus Oct 1, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Sep 30, 2024 Sep 30, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 17, 2024 Sep 17, 2024
8-K Current report
Regulation FD disclosure
Sep 11, 2024 Sep 11, 2024
424B3 Prospectus Aug 22, 2024 —
424B3 Prospectus Aug 22, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Aug 22, 2024 Aug 22, 2024
424B3 Prospectus Aug 15, 2024 —
424B3 Prospectus Aug 15, 2024 —
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
424B3 Prospectus Aug 13, 2024 —
424B3 Prospectus Aug 13, 2024 —
424B3 Prospectus Aug 13, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Aug 13, 2024 Aug 13, 2024
8-K Current report
Regulation FD disclosure, Other events
Aug 1, 2024 Aug 1, 2024
424B3 Prospectus Jul 19, 2024 —
424B3 Prospectus Jul 19, 2024 —
424B3 Prospectus Jul 19, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Jul 18, 2024 Jul 18, 2024
424B3 Prospectus Jul 10, 2024 —
424B3 Prospectus Jul 9, 2024 —
424B3 Prospectus Jul 9, 2024 —
424B3 Prospectus Jul 9, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Jul 9, 2024 Jul 9, 2024
8-K Current report
Regulation FD disclosure, Other events
Jul 8, 2024 Jul 8, 2024
EFFECT Filing Jul 3, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Jul 3, 2024 Jul 3, 2024
CORRESP Letter to the SEC Jul 1, 2024 —
8-K Current report
Material agreement
Jul 1, 2024 Jul 1, 2024
424B5 Prospectus supplement Jul 1, 2024 —
EFFECT Filing Jun 21, 2024 —
S-1/A Amended registration statement Jun 20, 2024 —
D Filing Jun 20, 2024 —
UPLOAD Letter from the SEC Jun 20, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Jun 17, 2024 Jun 17, 2024
POS AM Filing Jun 11, 2024 —
S-1 Registration statement Jun 11, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jun 4, 2024 Jun 3, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
MBOT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Hingham, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
883975
Former names
Microbot Medical Inc. (until Nov 3, 2026); STEMCELLS INC (until Nov 15, 2016); CYTOTHERAPEUTICS INC/DE (until May 15, 2000)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.